Cleveland, Ohio-based Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced today a $1.8m Series A round of financing led by the North Coast Angel Fund (NCAF) with participation from Glengary LLC, Ohio Tech Angel Fund and Queen City Angels First Fund III.
This round follows the initial investment made earlier in the year from JumpStart Ventures and Case Technology Ventures.
The funds will be used to develop products, expand its management team and complete clinical studies.
The company’s initial target is focused on the chronic pain market, including residual limb pain, chronic post surgical pain, and chronic migraine. Its patented platform technology Nerve Block delivers high-frequency stimulation to sensory nerves in the peripheral nervous system to block chronic pain.